C3 and dermatomyositis: In patients with dermatomyositis, a complement-dependent microangiopathy mediated by activation of C3 and deposition of MAC on the endomysial capillaries [45], IVIg is not only clinically effective [46] but also inhibits complement uptake, intercepting the formation and deposition of MAC on the endomysial capillaries [46, 47].